World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 14 March 2022
Main ID:  NCT01880541
Date of registration: 06/11/2012
Prospective Registration: No
Primary sponsor: Institut Bergonié
Public title: Assessment of Cognitive Function After Surgery in Two Types of Anesthesia in Patients Operated for Breast Cancer HYPNOSEIN
Scientific title: Assessment of Cognitive Function After Surgery in Two Types of Anesthesia (General Anesthesia Hypnosedation or Traditional) in Patients Operated for Breast Cancer
Date of first enrolment: December 2010
Target sample size: 30
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT01880541
Study type:  Interventional
Study design:  Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
France
Contacts
Name:     COLOMBANI Sylvie, MD
Address: 
Telephone:
Email:
Affiliation:  Institut Bergonié
Key inclusion & exclusion criteria

Inclusion Criteria:

- Female, over 18 and under 80 years

- Diagnosis of breast cancer established (Pathology)

- Life expectancy greater than 6 months

- Surgery of breast lumpectomy with or without lymph node dissection, mastectomy with or
without lymph node dissection, dissection isolated

- ASA 1 (healthy patient) or 2 (patient with moderate to high function) according to the
classification of the American Society of Anesthesiologist,

- Affiliation to a social security scheme,

- Information on the study, signed informed consent

Exclusion Criteria:

- Presence of major psychiatric disorders or psychotic behavior addiction, evaluated by
neuropsychologist at the first preoperative consultation, through the test MINI (MINI>
4 positive responses for each module)

- Presence of neurological disorders known untreated or evaluated by neuropsychologist
at the first preoperative consultation, with the MMSE test (MMSE <24)

- Patient treated morphine orally for 3 months or more

- Patient is pregnant or nursing, or of childbearing potential and not using adequate
contraception,

- Patient included in another clinical study

- Inability to undergo medical monitoring study for geographical, social or
psychological

- Patient deprived of liberty and most subject to a measure of legal protection or
unable to consent



Age minimum: 18 Years
Age maximum: N/A
Gender: Female
Health Condition(s) or Problem(s) studied
Patients With Breast Cancer and Breast Surgery Requiring
Intervention(s)
Other: hypnosedation
Other: general anesthésia
Primary Outcome(s)
Presence of Cognitive Impairment [Time Frame: on the 7th day following surgery]
Secondary Outcome(s)
Presence of Cognitive Impairment [Time Frame: 1 month after surgery]
Secondary ID(s)
IB2009-71
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available: Yes
Date Posted: 04/03/2022
Date Completed:
URL: https://clinicaltrials.gov/ct2/show/results/NCT01880541
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history